The DOJ has sued top Medicare Advantage insurers and brokers alleging illegal kickbacks to steer enrollments, raising regulatory and compliance issues in the Medicare insurance market.
Explore challenges patients face with ACA preventive care coverage where diagnostic lab tests during annual checkups lead to unexpected bills. Understand insurer policies, site-neutral payment reform, and regulatory risks affecting U.S. health insurance and preventive services.
Elevance Health halts digital enrollment in most Medicare Advantage plans amid rising expenses seen at UnitedHealth Group, affecting broker sign-ups and market growth dynamics.
Sharp Medicare Supplement premium increases reflect rising healthcare use, billing complexities, and enrollment shifts, urging beneficiaries to evaluate plan and underwriting options.
New York City faces a policy debate as Mayor Adams pushes privatized Medicare Advantage plans for 250,000 municipal retirees, with opponents pledging to reverse the shift. Explore the insurance and market impacts of this change.
Medicare Advantage plans face increasing provider disputes leading to special enrollment periods for affected members, raising regulatory and beneficiary access concerns.
Centene reports strong Q1 2025 financial results with earnings growth, expanded Medicaid and Medicare membership, and raised revenue guidance. Strategic contract renewals support its market expansion in government-sponsored healthcare programs.
Pennsylvania risks losing $500 million in federal funding for crucial public health programs, affecting vaccine administration, disease surveillance, and contact tracing efforts. Insights on regulatory and market impacts.
New York City municipal retirees oppose the city's plan to switch from traditional Medicare to Medicare Advantage plans, citing concerns over healthcare access and coverage delays. Legal and legislative efforts seek to preserve retirees' healthcare choice.
Centene's Q1 2025 earnings reveal challenges from potential Medicaid cuts, ACA subsidy expiration, and CMS rules, impacting pricing and enrollment in U.S. health insurance markets.
